Back to news

Nanox to Showcase Its Innovative Technology and Advances Across Nanox.ARC X and Nanox.AI at RSNA 2026

Globe Newswire•18/11/2026•08:10 ET
0

Key Highlights

  • ➤Nanox.ARC X FDA-cleared tomosynthesis system to be demonstrated at RSNA 2026
  • ➤Nanox.AI FDA-cleared algorithms analyze routine CT scans for chronic disease signs
  • ➤Nanox previews multiplanar reconstruction, pediatric imaging, and Mobile Nanox.ARC developments
  • ➤Nanox previews AI assessments for aortic valve calcification and body composition

Expert Statements

Erez Meltzer, Chief Executive Officer of Nanox

“Innovation is at the core of what we build at Nanox, from the proprietary digital X-ray technology behind Nanox.ARC X, which TIME named one of its Best Inventions of 2026, to AI that helps clinicians identify early signs of chronic disease in routine CT scans. At RSNA, we're showing what Nanox offers today and previewing what we're developing next, all with one goal: to enable earlier detection and broaden access to care”

Lawrence Tanenbaum, MD, Chief Medical Officer, U.S., Nanox

“Medical imaging contains far more information than is often captured”

Lawrence Tanenbaum, MD, Chief Medical Officer, U.S., Nanox

“We are demonstrating how our innovative technology can unlock more of that information, from the advanced capabilities of the Nanox.ARC X to identifying additional health insights from routine CT scans with Nanox.AI.”

* Exhibiting at RSNA Booth #1759 (South Hall Level 3), featuring live demonstrations of TIME Best Inventions of 2026 honoree Nanox.ARC X and Nanox.AI solutions, part of Nanox’s integrated, end-to-end medical imaging and healthcare services platform * Industry Expert Theater presentation by CEO Erez Meltzer and Lawrence Tanenbaum, MD, Chief Medical Officer, U.S., Nanox, to highlight Nanox’s end-to-end imaging ecosystem (Nov. 30 at 10:30 am CT) * Innovation Theater presentation by Cedars-Sinai cardiologist Ofir Koren, MD, to highlight aortic valve calcification AI solution (Dec. 1 at 11:00 am CT) PETACH TIKVA, Israel, Nov. 18, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (“Nanox” or the “Company”, Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will showcase technologies designed to enable earlier detection and broader access to care at the Radiological Society of North America (RSNA) 2026 Annual Meeting: Nanox.ARC X, a TIME Best Inventions of 2026 honoree and FDA-cleared multi-source digital tomosynthesis system powered by proprietary digital X-ray technology, and Nanox.AI, FDA-cleared AI that analyzes routine CT scans to identify early signs of chronic conditions. The Company will also preview new innovations in development. RSNA is taking place November 29 to December 2, 2026, Chicago, IL.

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in